Dr. Jason Robert Guertin is a researcher at the Centre de recherche du CHU de Québec – Laval University and an assistant professor in the Department of Preventive and Social Medicine of Université Laval’s Faculty of Medicine.

Financial evaluation is a pivotal component of health technology assessment. It aims to support decision-makers to establish if adopting a novel health technology represents the most efficient use of available resources. Considering that healthcare demands are continuously on the rise, and budgets are overstretched, many health technology assessment units in Canada and abroad are examining the option of reassessing the value of previously adopted technologies using observational economic revaluations. Dr. Guertin’s research program focuses on the various components of economic evaluations and revaluations conducted within an observational setting. More recently, his work has focused on: 1) the development of novel methods aimed at addressing limits associated with observational economic evaluations; 2) evaluating the impact of chronic diseases on patients’ health-related quality of life in Quebec and Canada; and 3) the economic evaluation of health technologies in the field of personalized medicine.

Hôpital Saint-Sacrement
1050 Chemin Sainte-Foy
Bureau J0-09
Ville de Québec, QC
Canada G1S 4L8
42 entries « 1 of 5 »

Fillion V, Sirois MJ, Gamache P, Guertin JR, Morin SN, Jean S

Frailty and health services use among Quebec seniors with non-hip fractures: a population-based study using adminsitrative databases.

Journal Article

BMC Health Serv Res, 19 (1), pp. 70, 2019.

Abstract | Links:

Guertin JR, Humphries B, Feeny D, Tarride JE

Health Utilities Index Mark 3 scores for major chronic conditions: Population norms for Canada based on the 2013 and 2014 Canadian Community Health Survey.

Journal Article

Health Rep, 29 (11), pp. 12-19, 2018, ISSN: 0840-6529.

Abstract | Links:

Muratov S, Lee J, Holbrook A, Costa A, Paterson JM, Guertin JR, Mbuagbaw L, Gomes T, Khuu W, Tarride JE

Regional variation in healthcare spending and mortality among senior high-cost healthcare users in Ontario, Canada: a retrospective matched cohort study.

Journal Article

BMC Geriatr, 18 (1), pp. 262, 2018.

Abstract | Links:

Tarride JE, Smofsky A, Nykoliation P, Allain S, Lewis-Daly L, Satok D, Schwartz J, Pollack JH, Guertin JR, McIntyre RS

Effectiveness of a Type 2 Diabetes Screening Intervention in the Canadian Workplace.

Journal Article

Can J Diab, 42 (5), pp. 493-499.e1, 2018, ISSN: 1499-2671.

Abstract | Links:

Guertin JR, Feeny D, Tarride JE

Age- and sex-specific Canadian utility norms, based on the 2013-2014 Canadian Community Health Survey.

Journal Article

CMAJ, 190 (6), pp. E155-E161, 2018, ISSN: 0820-3946.

Abstract | Links:

Nabi H, Guertin JR, Talbot D, Diorio C

Body-mass index and metastatic melanoma outcomes.

Journal Article

Lancet Oncol, 19 (5), pp. e226, 2018, ISSN: 1470-2045.

| Links:

Mitchell D, Guertin JR, Dubois A, Dube MP, Tardif JC, Iliza AC, Fanton-Aita F, Matteau A, LeLorier J

A Discrete Event Simulation Model to Assess the Economic Value of a Hypothetical Pharmacogenomics Test for Statin-Induced Myopathy in Patients Initiating a Statin in Secondary Cardiovascular Prevention.

Journal Article

Mol Diagn Ther, 22 (2), pp. 241-254, 2018, ISSN: 1177-1062.

Abstract | Links:

Tarride JE, Hopkins RB, Burke N, Guertin JR, O'Reilly D, Fell CD, Dion G, Kolb M

Clinical and economic burden of idiopathic pulmonary fibrosis in Quebec, Canada.

Journal Article

Clinicoecon Outcomes Res, 10 , pp. 127-137, 2018, ISSN: 1178-6981.

Abstract | Links:

Fanton-Aita F, Matteau A, Potter BJ, Guertin JR, Mitchell D, Iliza AC, Dubois A, Dubé MP, Tardif JC, LeLorier J

Framework for the cost-effectiveness of secondary prevention strategies in cardiovascular diseases: A Canadian theoretical model-based analysis

Journal Article

Journal of pharmacology research, 1 (1), pp. 1-6, 2018.

| Links:

Mitchell D, Guertin JR, LeLorier J

Value of a Hypothetical Pharmacogenomic Test for the Diagnosis of Statin-Induced Myopathy in Patients at High Cardiovascular Risk.

Journal Article

Mol Diagn Ther, 22 (6), pp. 641-652, 2018, ISSN: 1177-1062.

Abstract | Links:

42 entries « 1 of 5 »
Signaler des modifications

Active projects

  • Canadian Program for Monitoring Overuse in Injury Care, Subvention, Instituts de recherche en santé du Canada, Subventions Fondation, from 2016-07-01 to 2021-06-30
  • Centre hospitalier universitaire de Québec - Université Laval, Subvention, Centre hospitalier universitaire de Québec - Université Laval, Centres de recherche affiliés, from 2017-01-01 to 2099-12-31
  • PEGASUS-2 - PErsonalized Genomics for prenatal Abnormalities Screening USing maternal blood : Towards First Tier Screening and Beyond, Partenariat, Génome Canada, Projets de recherche appliquée à grande échelle, from 2018-04-01 to 2022-03-31
  • Real-World Cost-Effectiveness of Direct Oral Anticoagulants in Atrial Fibrillation: A Canadian Health Technology Reassessment Study, Subvention, Instituts de recherche en santé du Canada, Subvention Projet, from 2018-04-01 to 2020-09-30

Recently finished projects

  • Formation et soutien en évaluation économique et économie de la santé pour les chercheurs, décideurs et professionnels de la santé, Subvention, Instituts de recherche en santé du Canada, Unités de soutien de la stratégie de recherche axée sur le patient(SRAP), from 2017-06-01 to 2018-03-31
  • Optimizing the use of real-world cost, utilization and cost-effectiveness data when conducting health technology reassessments, Subvention, Instituts de recherche en santé du Canada, Autre: Bourse de voyage - Appui communautaire des instituts, from 2017-04-01 to 2018-03-31
Data provided by the Université Laval research projects registery